US regulators defend requiring more data on monkeypox drug - SABC News

8/3/2022 12:00:00 AM2 years 9 months ago

As US monkeypox cases rise, US health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies' experimental drug TPOXX is safe and effective to treat the virus.

As US monkeypox cases rise, US health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies’ experimental dru… [+3329 chars]

full article...